Related Experiment Video
Updated: Feb 14, 2026
05:18
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
1.9K
[Research progress of ocular sustained-release corticosteroid delivery systems]
1Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|February 13, 2018
Summary
Conventional ocular drug delivery faces challenges reaching target tissues. Sustained-release systems offer improved drug concentrations and reduced injection frequency for chronic eye diseases.
Area of Science:
- Ophthalmology
- Pharmaceutics
- Biomaterials
Background:
- Conventional ocular drug delivery struggles to achieve and maintain therapeutic concentrations due to anatomical and physiological barriers.
- Chronic posterior segment ocular diseases necessitate advanced drug delivery systems to overcome these barriers for effective treatment.
Purpose of the Study:
- To review current sustained-release corticosteroid delivery systems for ocular diseases.
- To highlight the advantages of sustained-release systems in improving ocular drug delivery efficacy.
Main Methods:
- Literature review of sustained-release corticosteroid delivery systems for ocular applications.
- Discussion of challenges and advancements in ocular drug delivery.
Main Results:
- Ocular sustained-release drug delivery systems show promise in enhancing local drug concentration and prolonging therapeutic effects.
- These systems can reduce the frequency of injections, improving patient compliance.
Conclusions:
- Sustained-release systems represent a significant advancement in ocular drug delivery, particularly for posterior segment diseases.
- Further development of effective sustained-release systems is crucial for improving clinical outcomes in managing chronic ocular conditions.
Related Concept Videos
01:26Oral Drug Delivery Systems: Continuous-Release Systems
20
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
20
01:11Oral Drug Delivery Systems: Delayed-Release Systems
23
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
23
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
18
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
18
01:30Modified-Release Drug Delivery Systems: Bioavailability
16
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
16
01:19Modified-Release Drug Delivery Systems: Overview
17
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
17
01:23Modified-Release Drug Delivery Systems: Classification
18
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
18